{"entity":{"type":"insider","cik":"0001301173","url":"/insider/0001301173","json_url":"/insider/0001301173.json","name":"Cooper Jeffrey H","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":82,"n_filings":31,"first":"2006-02-27","last":"2012-05-16","span_basis":"filed_date"},"name_variants":[{"name":"Cooper Jeffrey H","source":"filing","n_filings":31,"first_seen":"2006-02-27","last_seen":"2012-05-16"}],"transactions":[{"id":3441775,"accession":"0001140361-12-025912","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-12-025912","line_url":"/filing/0001140361-12-025912#line-5","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25250.0,"shares_display":"25,250","price_per_share":38.0878,"price_display":"38.09","price_state":"stated","total_value":961716.95,"total_display":"961,716.95","shares_owned_after":41089.0,"shares_owned_after_display":"41,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-14","filed_date":"2012-05-16","scope":"insider"},{"id":3496332,"accession":"0001140361-12-011429","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-12-011429","line_url":"/filing/0001140361-12-011429#line-6","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":83036.0,"shares_display":"83,036","price_per_share":35.069,"price_display":"35.07","price_state":"stated","total_value":2911989.484,"total_display":"2,911,989.48","shares_owned_after":40104.0,"shares_owned_after_display":"40,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-24","filed_date":"2012-02-28","scope":"insider"},{"id":2784044,"accession":"0001140361-12-001329","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-12-001329","line_url":"/filing/0001140361-12-001329#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":34.752,"price_display":"34.75","price_state":"stated","total_value":86880.0,"total_display":"86,880.00","shares_owned_after":40104.0,"shares_owned_after_display":"40,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-03","filed_date":"2012-01-05","scope":"insider"},{"id":8832838,"accession":"0001140361-11-051579","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-11-051579","line_url":"/filing/0001140361-11-051579#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":33.258,"price_display":"33.26","price_state":"stated","total_value":83145.0,"total_display":"83,145.00","shares_owned_after":40104.0,"shares_owned_after_display":"40,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-01","filed_date":"2011-11-03","scope":"insider"},{"id":8959627,"accession":"0001140361-11-049128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-11-049128","line_url":"/filing/0001140361-11-049128#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18379.0,"shares_display":"18,379","price_per_share":34.0,"price_display":"34.00","price_state":"stated","total_value":624886.0,"total_display":"624,886.00","shares_owned_after":39876.0,"shares_owned_after_display":"39,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-10","filed_date":"2011-10-11","scope":"insider"},{"id":8863657,"accession":"0001140361-11-047377","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-11-047377","line_url":"/filing/0001140361-11-047377#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18379.0,"shares_display":"18,379","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":588128.0,"total_display":"588,128.00","shares_owned_after":39876.0,"shares_owned_after_display":"39,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-28","filed_date":"2011-09-29","scope":"insider"},{"id":9008487,"accession":"0001140361-11-044747","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-11-044747","line_url":"/filing/0001140361-11-044747#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":29.4052,"price_display":"29.41","price_state":"stated","total_value":73513.0,"total_display":"73,513.00","shares_owned_after":39876.0,"shares_owned_after_display":"39,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-01","filed_date":"2011-09-06","scope":"insider"},{"id":9090524,"accession":"0001140361-11-039627","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-11-039627","line_url":"/filing/0001140361-11-039627#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18036.0,"shares_display":"18,036","price_per_share":30.47,"price_display":"30.47","price_state":"stated","total_value":549556.92,"total_display":"549,556.92","shares_owned_after":39876.0,"shares_owned_after_display":"39,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-02","filed_date":"2011-08-04","scope":"insider"},{"id":9110132,"accession":"0001140361-11-037113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-11-037113","line_url":"/filing/0001140361-11-037113#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18378.0,"shares_display":"18,378","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":551340.0,"total_display":"551,340.00","shares_owned_after":39876.0,"shares_owned_after_display":"39,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-14","filed_date":"2011-07-18","scope":"insider"},{"id":9169092,"accession":"0001140361-11-036015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-11-036015","line_url":"/filing/0001140361-11-036015#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":68750.0,"total_display":"68,750.00","shares_owned_after":39876.0,"shares_owned_after_display":"39,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-01","filed_date":"2011-07-06","scope":"insider"},{"id":9169003,"accession":"0001140361-11-030496","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-11-030496","line_url":"/filing/0001140361-11-030496#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":481250.0,"total_display":"481,250.00","shares_owned_after":37876.0,"shares_owned_after_display":"37,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-26","filed_date":"2011-05-31","scope":"insider"},{"id":7190977,"accession":"0001140361-10-047226","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-10-047226","line_url":"/filing/0001140361-10-047226#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11250.0,"shares_display":"11,250","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":309375.0,"total_display":"309,375.00","shares_owned_after":26810.0,"shares_owned_after_display":"26,810","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-24","filed_date":"2010-11-24","scope":"insider"},{"id":7439996,"accession":"0001140361-10-042998","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-10-042998","line_url":"/filing/0001140361-10-042998#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19635.0,"shares_display":"19,635","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":490875.0,"total_display":"490,875.00","shares_owned_after":35601.0,"shares_owned_after_display":"35,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-29","filed_date":"2010-11-01","scope":"insider"},{"id":7439993,"accession":"0001140361-10-042998","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-042998","line_url":"/filing/0001140361-10-042998#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9115.0,"shares_display":"9,115","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":236990.0,"total_display":"236,990.00","shares_owned_after":26486.0,"shares_owned_after_display":"26,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-29","filed_date":"2010-11-01","scope":"insider"},{"id":7731114,"accession":"0001140361-10-042362","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-10-042362","line_url":"/filing/0001140361-10-042362#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15209.0,"shares_display":"15,209","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":365016.0,"total_display":"365,016.00","shares_owned_after":26486.0,"shares_owned_after_display":"26,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-25","filed_date":"2010-10-27","scope":"insider"},{"id":7242247,"accession":"0001140361-10-037370","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-10-037370","line_url":"/filing/0001140361-10-037370#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":22.851,"price_display":"22.85","price_state":"stated","total_value":137106.0,"total_display":"137,106.00","shares_owned_after":26486.0,"shares_owned_after_display":"26,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-13","filed_date":"2010-09-15","scope":"insider"},{"id":7578683,"accession":"0001048477-10-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001048477-10-000014","line_url":"/filing/0001048477-10-000014#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":82.0,"shares_display":"82","price_per_share":11.6025,"price_display":"11.60","price_state":"stated","total_value":951.405,"total_display":"951.40","shares_owned_after":18584.0,"shares_owned_after_display":"18,584","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-31","filed_date":"2010-02-25","scope":"insider"},{"id":5714983,"accession":"0001048477-09-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001048477-09-000014","line_url":"/filing/0001048477-09-000014#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":971.0,"shares_display":"971","price_per_share":13.949,"price_display":"13.95","price_state":"stated","total_value":13544.479,"total_display":"13,544.48","shares_owned_after":5046.0,"shares_owned_after_display":"5,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-31","filed_date":"2009-02-12","scope":"insider"},{"id":3815945,"accession":"0001048477-08-000167","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001048477-08-000167","line_url":"/filing/0001048477-08-000167#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1070.0,"shares_display":"1,070","price_per_share":13.949,"price_display":"13.95","price_state":"stated","total_value":14925.43,"total_display":"14,925.43","shares_owned_after":2075.0,"shares_owned_after_display":"2,075","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-30","filed_date":"2008-07-08","scope":"insider"},{"id":3128777,"accession":"0001048477-08-000025","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001048477-08-000025","line_url":"/filing/0001048477-08-000025#line-9","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":37.92,"price_display":"37.92","price_state":"stated","total_value":68256.0,"total_display":"68,256.00","shares_owned_after":4310.0,"shares_owned_after_display":"4,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":3128775,"accession":"0001048477-08-000025","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001048477-08-000025","line_url":"/filing/0001048477-08-000025#line-8","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":37.96,"price_display":"37.96","price_state":"stated","total_value":41756.0,"total_display":"41,756.00","shares_owned_after":3210.0,"shares_owned_after_display":"3,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":3128772,"accession":"0001048477-08-000025","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001048477-08-000025","line_url":"/filing/0001048477-08-000025#line-7","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":37.97,"price_display":"37.97","price_state":"stated","total_value":30376.0,"total_display":"30,376.00","shares_owned_after":2410.0,"shares_owned_after_display":"2,410","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":3128770,"accession":"0001048477-08-000025","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001048477-08-000025","line_url":"/filing/0001048477-08-000025#line-6","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":37.99,"price_display":"37.99","price_state":"stated","total_value":22794.0,"total_display":"22,794.00","shares_owned_after":1510.0,"shares_owned_after_display":"1,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":3128767,"accession":"0001048477-08-000025","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001048477-08-000025","line_url":"/filing/0001048477-08-000025#line-5","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":37.89,"price_display":"37.89","price_state":"stated","total_value":18945.0,"total_display":"18,945.00","shares_owned_after":6110.0,"shares_owned_after_display":"6,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":3128764,"accession":"0001048477-08-000025","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001048477-08-000025","line_url":"/filing/0001048477-08-000025#line-4","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":405.0,"shares_display":"405","price_per_share":38.0,"price_display":"38.00","price_state":"stated","total_value":15390.0,"total_display":"15,390.00","shares_owned_after":1105.0,"shares_owned_after_display":"1,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":3128760,"accession":"0001048477-08-000025","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001048477-08-000025","line_url":"/filing/0001048477-08-000025#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":37.98,"price_display":"37.98","price_state":"stated","total_value":11394.0,"total_display":"11,394.00","shares_owned_after":2110.0,"shares_owned_after_display":"2,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":3128757,"accession":"0001048477-08-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001048477-08-000025","line_url":"/filing/0001048477-08-000025#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":37.82,"price_display":"37.82","price_state":"stated","total_value":11346.0,"total_display":"11,346.00","shares_owned_after":6610.0,"shares_owned_after_display":"6,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":3128753,"accession":"0001048477-08-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001048477-08-000025","line_url":"/filing/0001048477-08-000025#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":38.01,"price_display":"38.01","price_state":"stated","total_value":3801.0,"total_display":"3,801.00","shares_owned_after":1005.0,"shares_owned_after_display":"1,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984689,"accession":"0001048477-08-000023","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-30","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10800.0,"shares_display":"10,800","price_per_share":37.6,"price_display":"37.60","price_state":"stated","total_value":406080.0,"total_display":"406,080.00","shares_owned_after":24155.0,"shares_owned_after_display":"24,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984678,"accession":"0001048477-08-000023","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-29","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8900.0,"shares_display":"8,900","price_per_share":37.57,"price_display":"37.57","price_state":"stated","total_value":334373.0,"total_display":"334,373.00","shares_owned_after":38830.0,"shares_owned_after_display":"38,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984673,"accession":"0001048477-08-000023","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-28","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7400.0,"shares_display":"7,400","price_per_share":37.56,"price_display":"37.56","price_state":"stated","total_value":277944.0,"total_display":"277,944.00","shares_owned_after":47730.0,"shares_owned_after_display":"47,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984668,"accession":"0001048477-08-000023","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-27","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3350.0,"shares_display":"3,350","price_per_share":37.58,"price_display":"37.58","price_state":"stated","total_value":125893.0,"total_display":"125,893.00","shares_owned_after":35480.0,"shares_owned_after_display":"35,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984663,"accession":"0001048477-08-000023","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-26","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2381.0,"shares_display":"2,381","price_per_share":37.65,"price_display":"37.65","price_state":"stated","total_value":89644.65,"total_display":"89,644.65","shares_owned_after":18667.0,"shares_owned_after_display":"18,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984660,"accession":"0001048477-08-000023","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-25","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":37.77,"price_display":"37.77","price_state":"stated","total_value":86871.0,"total_display":"86,871.00","shares_owned_after":7710.0,"shares_owned_after_display":"7,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984655,"accession":"0001048477-08-000023","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-24","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":37.68,"price_display":"37.68","price_state":"stated","total_value":71592.0,"total_display":"71,592.00","shares_owned_after":15167.0,"shares_owned_after_display":"15,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984649,"accession":"0001048477-08-000023","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-23","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1666.0,"shares_display":"1,666","price_per_share":37.61,"price_display":"37.61","price_state":"stated","total_value":62658.26,"total_display":"62,658.26","shares_owned_after":22489.0,"shares_owned_after_display":"22,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984644,"accession":"0001048477-08-000023","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-22","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":37.75,"price_display":"37.75","price_state":"stated","total_value":52850.0,"total_display":"52,850.00","shares_owned_after":11110.0,"shares_owned_after_display":"11,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984641,"accession":"0001048477-08-000023","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-21","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1208.0,"shares_display":"1,208","price_per_share":37.62,"price_display":"37.62","price_state":"stated","total_value":45444.96,"total_display":"45,444.96","shares_owned_after":21281.0,"shares_owned_after_display":"21,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984636,"accession":"0001048477-08-000023","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-20","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":37.76,"price_display":"37.76","price_state":"stated","total_value":41536.0,"total_display":"41,536.00","shares_owned_after":10010.0,"shares_owned_after_display":"10,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984631,"accession":"0001048477-08-000023","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-19","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":37.53,"price_display":"37.53","price_state":"stated","total_value":41283.0,"total_display":"41,283.00","shares_owned_after":55530.0,"shares_owned_after_display":"55,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984626,"accession":"0001048477-08-000023","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-18","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1017.0,"shares_display":"1,017","price_per_share":37.69,"price_display":"37.69","price_state":"stated","total_value":38330.73,"total_display":"38,330.73","shares_owned_after":14150.0,"shares_owned_after_display":"14,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984620,"accession":"0001048477-08-000023","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-17","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":37.67,"price_display":"37.67","price_state":"stated","total_value":33903.0,"total_display":"33,903.00","shares_owned_after":17067.0,"shares_owned_after_display":"17,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984615,"accession":"0001048477-08-000023","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-16","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":883.0,"shares_display":"883","price_per_share":37.7,"price_display":"37.70","price_state":"stated","total_value":33289.1,"total_display":"33,289.10","shares_owned_after":13267.0,"shares_owned_after_display":"13,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984611,"accession":"0001048477-08-000023","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-15","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":37.66,"price_display":"37.66","price_state":"stated","total_value":26362.0,"total_display":"26,362.00","shares_owned_after":17967.0,"shares_owned_after_display":"17,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984606,"accession":"0001048477-08-000023","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-14","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":557.0,"shares_display":"557","price_per_share":37.72,"price_display":"37.72","price_state":"stated","total_value":21010.04,"total_display":"21,010.04","shares_owned_after":12710.0,"shares_owned_after_display":"12,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984597,"accession":"0001048477-08-000023","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-13","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":525.0,"shares_display":"525","price_per_share":37.59,"price_display":"37.59","price_state":"stated","total_value":19734.75,"total_display":"19,734.75","shares_owned_after":34955.0,"shares_owned_after_display":"34,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984592,"accession":"0001048477-08-000023","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-12","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":37.78,"price_display":"37.78","price_state":"stated","total_value":18890.0,"total_display":"18,890.00","shares_owned_after":7210.0,"shares_owned_after_display":"7,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984588,"accession":"0001048477-08-000023","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-11","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":37.55,"price_display":"37.55","price_state":"stated","total_value":15020.0,"total_display":"15,020.00","shares_owned_after":55130.0,"shares_owned_after_display":"55,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984583,"accession":"0001048477-08-000023","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-10","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":37.79,"price_display":"37.79","price_state":"stated","total_value":11337.0,"total_display":"11,337.00","shares_owned_after":6910.0,"shares_owned_after_display":"6,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":2984578,"accession":"0001048477-08-000023","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001048477-08-000023","line_url":"/filing/0001048477-08-000023#line-9","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001301173","owner_name":"Cooper Jeffrey H","owner_url":"/insider/0001301173","role":"Officer (SVP, Chief Financial Officer)","officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":37.63,"price_display":"37.63","price_state":"stated","total_value":7526.0,"total_display":"7,526.00","shares_owned_after":21081.0,"shares_owned_after_display":"21,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"}],"next_cursor":"2008-02-29|2984578","ledger_fault":false,"count":{"value":82,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":78,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":82},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001048477","name":"BIOMARIN PHARMACEUTICAL INC","url":"/issuer/0001048477","role":"Officer (SVP, Chief Financial Officer)","n_filings":31,"first_seen":"2006-02-27","last_seen":"2012-05-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001301173","retrieved_at":"2026-08-20T17:33:06+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}